The Near Point of Convergence in Patients with Vestibular Migraine.
Francisco Carlos Zuma E Maia, Bernardo Faria Ramos, Roseli Saraiva Moreira Bittar, Renato Valerio Rodrigues Cal, Leonel Almeida Lu��s, Pedro Luiz Mangabeira Albernaz
Author Information
Francisco Carlos Zuma E Maia: Department of Otorhinolaryngology, Cl��nica Maia, Canoas, RS, Brazil. ORCID
Bernardo Faria Ramos: Department of Otorhinolaryngology, Universidade Federal do Esp��rito Santo, Vit��ria, ES, Brazil. ORCID
Roseli Saraiva Moreira Bittar: Department of Otoneurology, Hospital das Cl��nicas da Universidade de S��o Paulo (HCFMUSP), S��o Paulo, SP, Brazil. ORCID
Renato Valerio Rodrigues Cal: Department of Otorhinolaryngology, Centro Universit��rio do Estado do Par�� (CESUPA), Bel��m, PA, Brazil. ORCID
Leonel Almeida Lu��s: Department of Otorhinolaryngology, Centro Hospitalar Universit��rio Lisboa Norte EPE, Lisboa, Portugal. ORCID
Pedro Luiz Mangabeira Albernaz: Department of Otorhinolaryngology, Hospital Israelita Albert Einstein, S��o Paulo, SP, Brazil. ORCID
���Vestibular migraine (VM) is one of the most common vestibular disorders and its diagnosis is based entirely on clinical features. A recent case series suggested a possible link between migraines and convergence insufficiency. ���To compare the near point of convergence (NPC) in patients with and without VM. ���We retrospectively reviewed the data of 50 patients with and 50 without VM, comparing the NPC between both groups. The NPC was measured according to the recommendations of the American Academy of Ophthalmology. Differences in the results between groups were compared using the Mann-Whitney test. The association of the NPC with age, gender, and the use of corrective glasses or contact lenses was evaluated by the Student or Mann-Whitney tests for parametric and nonparametric data, respectively. To determine the diagnostic accuracy and optimal cut-off point, receiver operating characteristic (ROC) curves were created. ���The mean NPC was significantly higher in patients with VM (18.50��������5.88���cm) compared to the control group (8.06��������1.46���cm; ���<���0.001). The area under the curve (AUC) was 0.986 (95% CI: 0.938-0.999; ���<���0.0001), suggesting that NPC was able to accurately discriminate between patients with and without VM with a sensitivity of 94% and specificity of 100%. ���Our results suggest that convergence insufficiency is a common sign in patients with VM and may be considered a potential clinical biomarker. However, further studies are needed to confirm this hypothesis.
